Top 10 Companies in the Global Gene Expression Detection Kit Market (2026): Market Leaders Powering Genomic Innovation

In Business Insights
May 21, 2026

MARKET INSIGHTS

Global Gene Expression Detection Kit Market size was valued at USD 689.2 million in 2024. The market is projected to grow from USD 742.5 million in 2025 to USD 1.47 billion by 2034, exhibiting a CAGR of 10.2% during the forecast period.

Gene expression detection kits are essential tools in molecular biology that enable researchers to study gene activity levels across different conditions. These kits utilize technologies like qPCR, microarrays, and RNA sequencing to measure mRNA levels, providing insights into cellular functions and disease mechanisms. Key product types include predesigned kits for common targets and customizable solutions for specialized research needs.

Global Gene Expression Detection Kit Market – View in Detailed Research Report


🔟 1. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: TaqMan assays, QuantStudio platforms

Thermo Fisher Scientific leads the market with its comprehensive portfolio of TaqMan assays and QuantStudio platforms, capturing approximately 25% of the market share in 2024. Their dominance stems from continuous product enhancements and strategic acquisitions, such as the 2024 acquisition of Olink Proteomics to enhance multiomics capabilities.

Sustainability & Growth Initiatives: Strategic acquisitions, multiomics expansion, commitment to sustainable lab practices.

  • Advanced assay technologies
  • Global distribution network
  • Robust R&D pipeline
  • Commitment to sustainability

9️⃣ 2. Qiagen

Headquarters: Hilden, Germany
Key Offering: Automated RNA/DNA extraction, RT-PCR solutions

Qiagen maintains strong positioning through its automated RNA/DNA extraction systems and RT-PCR solutions, particularly in clinical research applications.

Sustainability & Growth Initiatives: Focus on sustainable lab practices, partnerships with academic institutions.

  • Automated platforms
  • High-throughput solutions
  • Strong presence in clinical research
  • Global support network

8️⃣ 3. Bio‑Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: Droplet digital PCR technology

Bio‑Rad has gained traction with its droplet digital PCR technology, offering superior sensitivity for low‑abundance gene expression analysis.

Sustainability & Growth Initiatives: Investments in green manufacturing, open innovation.

  • High sensitivity assays
  • Robust data analytics
  • Global support network
  • Green manufacturing initiatives

7️⃣ 4. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: Microarray‑based and sequencing‑based solutions

Agilent offers advanced microarray and sequencing platforms, enabling high‑throughput gene expression analysis.

Sustainability & Growth Initiatives: Commitment to reducing chemical waste.

  • Integrated platforms
  • Data management tools
  • Strong R&D pipeline
  • Energy‑efficient instruments

6️⃣ 5. Illumina

Headquarters: San Diego, California, USA
Key Offering: Next‑generation sequencing, RNA‑Seq kits

Illumina dominates with its sequencing technologies, providing high‑throughput RNA‑Seq solutions for comprehensive transcriptomic profiling.

Sustainability & Growth Initiatives: Sustainable supply chain initiatives.

  • High‑throughput sequencing
  • Cloud‑based analytics
  • Global partnerships
  • Energy‑efficient workflows

5️⃣ 6. NanoString Technologies

Headquarters: Seattle, Washington, USA
Key Offering: GeoMx Digital Spatial Profiler, nCounter system

NanoString enables spatially resolved gene expression analysis, providing unique insights into tissue heterogeneity.

Sustainability & Growth Initiatives: Focus on data‑driven research.

  • Spatial profiling
  • Multiplex assays
  • User‑friendly platforms
  • Strong customer support

4️⃣ 7. Fluidigm

Headquarters: South San Francisco, California, USA
Key Offering: Integrated microfluidics panels

Fluidigm provides specialized panels for oncology and neuroscience research, leveraging microfluidics for high‑throughput analysis.

Sustainability & Growth Initiatives: Energy‑efficient instruments.

  • Microfluidic solutions
  • High‑throughput assays
  • Strong customer support
  • Innovation in instrumentation

3️⃣ 8. Roche

Headquarters: Basel, Switzerland
Key Offering: Automated diagnostic platforms

Roche offers automated solutions for biomarker discovery and validation, integrating seamlessly into clinical workflows.

Sustainability & Growth Initiatives: Circular economy initiatives.

  • Automation
  • Integration with clinical workflows
  • Global reach
  • Sustainability focus

2️⃣ 9. Bio‑Techne

Headquarters: Minneapolis, Minnesota, USA
Key Offering: Antibody‑based detection kits

Bio‑Techne provides high‑quality reagents for gene expression analysis, supporting diverse research applications.

Sustainability & Growth Initiatives: Eco‑friendly packaging.

  • High‑quality reagents
  • Broad catalog
  • Strong R&D
  • Eco‑friendly packaging

1️⃣ 10. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Reagent kits for molecular biology

Merck supplies reagent kits for research, emphasizing quality and innovation.

Sustainability & Growth Initiatives: Sustainability in manufacturing.

  • Reagent quality
  • Global distribution
  • Innovation
  • Sustainability focus

Download FREE Sample Report: Global Gene Expression Detection Kit Market – View in Detailed Research Report

Get Full Report: Global Gene Expression Detection Kit Market – View in Detailed Research Report

Outlook: The Future of Gene Expression Detection Kits

With a projected CAGR of 10.2% through 2034, the market is poised for robust growth driven by precision medicine, chronic disease management, and technological innovation. The Asia‑Pacific region is expected to be the fastest‑growing market, while North America remains the largest adopter due to advanced infrastructure and regulatory support.

Key Trends Shaping the Market

  • Precision medicine adoption across oncology and personalized therapies
  • Integration of liquid biopsy for non‑invasive monitoring
  • Automation and AI‑driven data analysis to enhance throughput
  • Single‑cell RNA sequencing for tumor heterogeneity studies
  • Regulatory harmonization to accelerate global commercialization
  • Expansion in emerging markets driven by national genomics initiatives